Originalmente publicado por Glock23
Ver Mensaje
"GlaxoSmithKline (GSK) plc today confirms that it has received three unsolicited, conditional and non-binding proposals from Unilever plc to acquire the GSK Consumer Healthcare business. The latest proposal received on 20th December 2021 was for a total acquisition value of £50 billion comprising £41.7 billion in cash and £8.3 billion in Unilever shares. The Consumer Healthcare business is a Joint Venture between GSK and Pfizer, with GSK holding a majority controlling interest of 68% and Pfizer 32%.
GSK rejected all three proposals made on the basis that they fundamentally undervalued the Consumer Healthcare business and its future prospects."
Quizá en un futuro vuelven a la carga ahora que es una empresa independiente y que les costaría menos de lo que querían pagar a GSK y por eso están desinvirtiendo... pero esto es especulación pura

Dejar un comentario: